Scholarships Awarded to Nine Students Affected by Dermatologic Conditions
LAVAL, Quebec, July 29, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced the recipients of their 2021 Aspire Higher scholarship program. The program, which began in 2012, will award nine students who have been treated for a dermatologic condition with a scholarship of up to $10,000 to pursue their undergraduate or graduate degrees.
"For nine years, Ortho Dermatologics has supported students in achieving their higher education goals through our Aspire Higher scholarship program. Beyond the demands of their schooling and extracurricular activities, these students have also had to manage the burden of living with a skin condition," said Scott Hirsch, senior vice president and chief strategy officer, Bausch Health, and president, Ortho Dermatologics. "The stories our 2021 scholarship recipients shared with us are inspiring, and we are honored to provide them with this award to recognize their achievements and help them pursue their academic aspirations."
The 2021 honorees were chosen from nearly 150 applications and were selected in part due to their essays overviewing their educational journeys while living with dermatologic conditions and the role a health care professional played in treating the condition. The applications were judged by an independent panel of dermatologists from across the country.
The Aspire Higher scholarship program recognizes students across a wide range of educational pursuits, with scholarships in three categories, including the Undergraduate Scholar Awards, the Graduate Scholar Awards, and the Today's Woman Scholar Awards for mothers pursuing undergraduate or graduate degrees.
The 2021 Aspire Higher scholarship program recipients are:
"Living with a skin condition can often be very difficult, especially when managing school – much of which was particularly challenging this year due to remote learning – and other activities. Thanks to the generosity of Ortho Dermatologics, I will be one step further toward achieving my goal of receiving a degree in Physical Therapy and Exercise Science," said Hillary Hardin, Felician University, North Bergen, N.J.
To learn more about the Aspire Higher scholarship program and to see stories from previous scholarship recipients, please visit www.AspireHigherScholarships.com. The 2022 Aspire Higher scholarship program will be accepting applications in early 2022.
About the Aspire Higher Scholarship Program
Since 2013, the Aspire Higher scholarship program has awarded 60 scholarships, providing students a total of $648,000 toward their higher education on campuses nationwide. The Aspire Higher scholarship program is now funded through the Bausch Foundation.
About the Bausch Foundation
In 2017, the Bausch Foundation was established to improve the lives of patients globally by providing access to safe, effective medicines and by financially supporting health care education and causes. Since its inception, the Bausch Foundation has contributed millions of dollars worth of financial and product donations to global charitable health organizations.
About Ortho Dermatologics
Ortho Dermatologics is one of the largest dermatology businesses dedicated to helping patients in the treatment of a range of therapeutic areas, including psoriasis, actinic keratosis, acne, atopic dermatitis and other dermatoses. In addition, the Ortho Dermatologics portfolio also includes several leading medical device systems for aesthetic applications, such as skin tightening and resurfacing, laser hair removal and other preventative therapeutic skin care treatments. More information can be found at www.ortho-dermatologics.com.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.
Forward-looking Statements
This news release may contain forward-looking statements, which may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch Health's most recent annual report on Form 10-K and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. They also include, but are not limited to, risks and uncertainties caused by or relating to the evolving COVID-19 pandemic, and the fear of that pandemic and its potential effects, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on Bausch Health, including but not limited to its project development timelines, and costs (which may increase). Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
Ortho Dermatologics is a trademark of Ortho Dermatologics' affiliated entities.
© 2021 Ortho Dermatologics' affiliated entities.
ORD.0126.USA.21
Bausch Health Investor Contact:
Arthur Shannon
[email protected]
(514) 865-3855
(877) 281-6642 (toll free)
Bausch Health Media Contact:
Lainie Keller
[email protected]
(908) 927-1198
SOURCE Bausch Health Companies Inc.
Share this article